FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 335:670-672 August 29, 1996 Number 9 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Levine, M. PubMed Citation

To the Editor: The studies on low-molecular-weight heparin by Levine et al. and by Koopman et al. (March 14 issue)^1,2 addressed the safety and efficacy of low-molecular-weight heparin given at home, as compared with standard heparin given in the hospital, for acute proximal deep venous thrombosis. There did not appear to be any differences between the two treatment groups in terms of bleeding, pulmonary embolism, recurrent thromboembolic events, or death. The cost savings to the health care system could be substantial. I have several reservations about these studies, since many of the short-term and long-term problems that develop from deep-vein . . . [Full Text of this Article]

References

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.